Corneal WFG Versus AF Trans PRK in Myopic Patients With High Corneal HOA
Myopia
About this trial
This is an interventional treatment trial for Myopia focused on measuring aberration free, corneal wavefront guided, higher order aberrations, photorefractive keratectomy.
Eligibility Criteria
Inclusion Criteria:
- Myopic patients with or without astigmatism
Exclusion Criteria:
- severe dry eye,
- blepharitis,
- corneal disease,
- contact lens warpage,
- cataract,
- uveitis
- posterior segment anomalies involving the macula or optic nerve
- systemic conditions; diabetes mellitus, connective tissue disease, pregnancy or nursing. Also, any patient who had previous ocular surgery including keratorefractive surgery was excluded
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
42 eyes in aberration free group
24 eyes in corneal WFG group
TransPRK was performed to eligible myopic patients with or without astigmatism with corneal HOAs ≥ 0.35 µ utilizing aberration free in aberration free group provided by ORKCAM software (SCHWIND eye-tech-solutions, Kleinostheim, Germany)
TransPRK was performed to eligible myopic patients with or without astigmatism with corneal HOAs ≥ 0.35 µ utilizing corneal WFG patterns in corneal WFG group provided by ORKCAM software (SCHWIND eye-tech-solutions, Kleinostheim, Germany)